Delivery Order SPE2DB22D2211-SPE2DB25FSFKQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50 under a firm fixed price arrangement. The award was made on August 7, 2025, with an ultimate completion date of August 28, 2025. This non-competitive delivery order represents a small-value pharmaceutical supply transaction, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $9,122.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on September 12, 2025, with completion targeted for October 3, 2025. This non-competitive delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gel-One 30 mg/3 mL syringes valued at $9,122.50 with completion scheduled for October 7, 2025. This firm fixed-price delivery order, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,649.00 delivery order contract to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity) with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,459.60. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The product will be performed at the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $4,013.90. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,298.00 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of October 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,649.00 delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on September 9, 2025, with completion targeted for September 30, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed-price arrangement for pharmaceutical supply delivery to support federal medical procurement needs. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $10,947.00 and ultimate completion date of October 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Gel-One is...
- The Defense Logistics Agency awarded a $18,245 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a completion date of July 11, 2025. This non-set-aside, firm fixed price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's extensive federal pharmaceutical distribution portfolio and is issued under the company's larger...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFKQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $10,947.00 and a firm fixed price structure. This delivery order represents a competitive award with no set-aside designation and is expected to reach completion by October 10, 2025. The award leverages AmerisourceBergen's established relationship with DLA through its broader pharmaceutical supply agreements, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates under a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the framework for this delivery order. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other federal healthcare entities worldwide. This specific delivery order for Gel-One, an ophthalmic viscosurgical device used in eye surgery procedures, exemplifies the company's role in fulfilling specialized medical supply needs for the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 9/19/25 |